The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 12, 2021
Filed:
Nov. 08, 2019
Applicant:
Klox Technologies Inc., Laval, CA;
Inventors:
Remigio Piergallini, A.P., IT;
Nikolaos Loupis, Athens, GR;
Assignee:
KLOX TECHNOLOGIES INC., Québec, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 33/40 (2006.01); A61K 41/00 (2020.01); A61K 31/4166 (2006.01); A61K 31/7008 (2006.01); A61K 31/728 (2006.01); A61K 45/06 (2006.01); A61K 8/38 (2006.01); A61K 8/49 (2006.01); A61K 8/60 (2006.01); A61K 8/73 (2006.01); A61K 8/97 (2017.01); A61N 5/06 (2006.01); A61Q 11/00 (2006.01); A61Q 17/00 (2006.01); A61K 31/327 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 41/0057 (2013.01); A61K 8/38 (2013.01); A61K 8/494 (2013.01); A61K 8/498 (2013.01); A61K 8/602 (2013.01); A61K 8/735 (2013.01); A61K 8/97 (2013.01); A61K 9/006 (2013.01); A61K 31/327 (2013.01); A61K 31/4166 (2013.01); A61K 31/7008 (2013.01); A61K 31/728 (2013.01); A61K 33/40 (2013.01); A61K 41/008 (2013.01); A61K 41/0038 (2013.01); A61K 41/0042 (2013.01); A61K 45/06 (2013.01); A61N 5/062 (2013.01); A61N 5/0603 (2013.01); A61N 5/0624 (2013.01); A61Q 11/00 (2013.01); A61Q 17/005 (2013.01); A61N 2005/0606 (2013.01); A61N 2005/0652 (2013.01); A61N 2005/0663 (2013.01);
Abstract
The present document describes methods of use of photo activated compositions for oral disinfection and/or treatments which comprise at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmacologically acceptable carrier.